VP, Clinical Development — Hematology & Oncology

Scorpion Therapeutics; South San Francisco (CA); On-site; USD 350,000 - 600,000; Full time

Job summary

Rigel is seeking a Vice President, Clinical Development to provide executive leadership for hematology and oncology programs. Based at the South San Francisco headquarters, you will oversee global trial design, planning, and execution across therapeutic areas, ensuring alignment with regulatory objectives.

You will develop clinical strategies, drive trial quality and safety monitoring, collaborate with Biometrics, Clinical Operations, Regulatory, and Drug Safety, and support regulatory

Qualifications

• MD with hematology/oncology specialization.
• 8+ years in clinical research or drug development; 6+ years in industry.
• Experience with global regulatory agencies, trial design, and data interpretation.
• Strong leadership and cross-functional collaboration skills.

Responsibilities

• Oversee clinical trial design, planning, and execution across programs.
• Develop and implement clinical strategies aligned with product lifecycle and regulatory goals.
• Ensure trial quality, regulatory compliance, data integrity, and safety monitoring.
• Collaborate with Biometrics, Clinical Operations, Regulatory, and Drug Safety.
• Support regulatory interactions and external stakeholder engagement.
• Contribute to portfolio-level decision-making and long-term capabilities.

Skills

Leadership

Cross-functional collaboration

Communication

Regulatory engagement

Clinical trial design

Education

MD in Hematology/Oncology

Job description

Rigel is seeking a Vice President, Clinical Development to provide executive leadership for hematology and oncology programs. Based at the South San Francisco headquarters, you will oversee global trial design, planning, and execution across therapeutic areas, ensuring alignment with regulatory objectives.

You will develop clinical strategies, drive trial quality and safety monitoring, collaborate with Biometrics, Clinical Operations, Regulatory, and Drug Safety, and support regulatory